Multisystem inflammatory syndrome in children and Kawasaki disease
Open Access
- 15 April 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1554787
Abstract
This narrative review aims to analyze and compare the current literature on multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease (KD), with a focus on case definitions, clinical features, diagnostic approaches, treatment strategies, and outcomes. Through a comprehensive review of relevant studies, including screening titles, abstracts, and full-text articles, key similarities and differences were identified. Both MIS-C and KD involve immune system dysregulation and share clinical manifestations such as rash, gastrointestinal symptoms, and cardiovascular involvement, with treatments often centered around immunomodulatory therapies. However, significant differences were observed, particularly in terms of age distribution, demographic prevalence, clinical presentation, and diagnostic criteria, with KD primarily affecting younger children and being associated more prominently with coronary artery abnormalities. While both diseases raise concerns about severe cardiac involvement and the need for intensive care, their pathogenic mechanisms have not been fully understood. Ongoing research is critical to elucidating these mechanisms, refining diagnostic criteria, and optimizing therapeutic approaches to improve outcomes for affected children. This comparative analysis is essential for advancing the understanding of both conditions, as accurately distinguishing between MIS-C and KD has significant implications for clinical decision-making and patient management. Given their overlapping yet distinct clinical features, precise differentiation is critical for ensuring timely diagnosis, optimizing therapeutic strategies, and improving patient outcomes. The concern among pediatric patients stems from the potential for severe complications, particularly cardiac involvement, which underscores the need for heightened awareness, early recognition, and evidence-based treatment strategies to minimize long-term morbidity and mortality.Keywords
This publication has 103 references indexed in Scilit:
- Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki diseasePediatric Pulmonology, 2021
- Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 PandemicJAMA Pediatrics, 2021
- Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2JAMA Network Open, 2021
- How we approach thrombosis risk in children with COVID‐19 infection and MIS‐CPediatric Blood & Cancer, 2021
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysisReviews in Medical Virology, 2020
- Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and AdultsJAMA, 2020
- Diagnosis and Management of Kawasaki DiseaseJAMA Pediatrics, 2019
- Atorvastatin Safety in Kawasaki Disease Patients With Coronary Artery AneurysmsPediatric Cardiology, 2013
- Urine proteomics for discovery of improved diagnostic markers of Kawasaki diseaseEMBO Molecular Medicine, 2012
- Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-α and interleukin-1β by peripheral blood monocytes in the acute phase of Kawasaki diseaseEuropean Journal of Pediatrics, 1996